Finance Watch: BioAtla, Virios And Scopus Launch Latest US IPOs
Harbour BioMed And Jacobio Went Public In Hong Kong
Public Company Edition: Initial public offerings may take a holiday break, but 2020 already has been a remarkable year for IPOs in the US and China. Also, Arvinas led the latest follow-ons with a $400m offering followed by TG Therapeutics with a $275m stock sale.
